NCT03859622View on ClinicalTrials.gov

CYP2D6 Polymorphism in Patients of General Practice in Austria

CompletedOBSERVATIONAL
Enrollment

289

Participants

Timeline

Start Date

October 9, 2017

Primary Completion Date

October 9, 2018

Study Completion Date

October 9, 2018

Conditions
Disorder Due Cytochrome P450 CYP2D6 Variant
Trial Locations (1)

A 2261

Practice Office, Angern

All Listed Sponsors
lead

Karl Landsteiner Institute for Systematics in General Medicine

OTHER

NCT03859622 - CYP2D6 Polymorphism in Patients of General Practice in Austria | Biotech Hunter | Biotech Hunter